Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.
about
Seronegative Neuromyelitis Optica Spectrum Disorder following Exposure to Hepatitis B Vaccination.Differential diagnosis of neuromyelitis optica spectrum disorders.Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome StudyMOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders
P2860
Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Seronegative Neuromyelitis Opt ...... e definition and pathogenesis.
@ast
Seronegative Neuromyelitis Opt ...... e definition and pathogenesis.
@en
type
label
Seronegative Neuromyelitis Opt ...... e definition and pathogenesis.
@ast
Seronegative Neuromyelitis Opt ...... e definition and pathogenesis.
@en
prefLabel
Seronegative Neuromyelitis Opt ...... e definition and pathogenesis.
@ast
Seronegative Neuromyelitis Opt ...... e definition and pathogenesis.
@en
P2093
P2860
P1476
Seronegative Neuromyelitis Opt ...... e definition and pathogenesis.
@en
P2093
Dagoberto Callegaro
Ichiro Nakashima
Kazuo Fujihara
Marco Aurélio Lana-Peixoto
P2860
P304
P356
10.1590/0004-282X20140032
P50
P577
2014-06-01T00:00:00Z